Vor Bio announced on September 2, 2025, the appointment of Adi Osovsky, S.J.D., as General Counsel. Dr. Osovsky brings 17 years of corporate counsel and law firm experience within the biotechnology and pharmaceutical sectors.
Her proven experience advising public biopharmaceutical companies on governance, compliance, and strategic transactions makes her an important addition to the leadership team. Dr. Osovsky previously served as Executive Vice President, Head of Legal & Corporate Secretary at iTeos Therapeutics.
Dr. Osovsky's counsel will be invaluable as Vor Bio advances its late-stage clinical programs and prepares for growth in the autoimmune disease space. This appointment strengthens the company's legal and strategic capabilities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.